Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage

Molecular Therapy

Volumn 22, Issue 3, 2014, Pages 645-654

  Van Velthoven, Cindy T J ^a   Braccioli, Luca ^a   Willemen, Hanneke L D M ^a   Kavelaars, Annemieke ^b   Heijnen, Cobi J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR LIKE 7; PERSEPHIN; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SIZE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; GENETICALLY MODIFIED MESENCHYMAL STEM CELL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE;

ERINACEIDAE; MUS;

ADENOVIRIDAE; ADMINISTRATION, INTRANASAL; ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; GENETIC VECTORS; HEDGEHOG PROTEINS; HYPOXIA-ISCHEMIA, BRAIN; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; OLIGODENDROGLIA; PROTEINS; TRANSDUCTION, GENETIC; TREATMENT OUTCOME;

EID: 84895431932     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.260     Document Type: Article

References (38)

1. van Velthoven, CT, Kavelaars, A, van Bel, F and Heijnen, CJ (2010). Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 30: 9603-9611.
2. van Velthoven, CT, Kavelaars, A, van Bel, F and Heijnen, CJ (2010). Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 24: 387-393.
3. van Velthoven, CT, Kavelaars, A and Heijnen, CJ (2012). Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr Res 71(4 Pt 2): 474-481.
4. Yasuhara, T, Matsukawa, N, Yu, G, Xu, L, Mays, RW, Kovach, J et al. (2006). Behavioral and histological characterization of intrahippocampal grafts of human bone marrowderived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant 15: 231-238.
5. Lee, JA, Kim, BI, Jo, CH, Choi, CW, Kim, EK, Kim, HS et al. (2010). Mesenchymal stemcell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr Res 67: 42-46.
6. Chen, J, Li, Y, Wang, L, Lu, M, Zhang, X and Chopp, M (2001). Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189: 49-57.
7. Zhang, ZG and Chopp, M (2009). Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8: 491-500.
8. van Velthoven, CT, Kavelaars, A, van Bel, F and Heijnen, CJ (2011). Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 25: 1342-1348.
9. Qu, R, Li, Y, Gao, Q, Shen, L, Zhang, J, Liu, Z et al. (2007). Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts. Neuropathology 27: 355-363.
10. Chen, X, Li, Y, Wang, L, Katakowski, M, Zhang, L, Chen, J et al. (2002). Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22: 275-279.
11. Ferriero, DM (2004). Neonatal brain injury. N Engl J Med 351: 1985-1995.
12. Park, H and Poo, MM (2013). Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 14: 7-23.
13. Schäbitz, WR, Steigleder, T, Cooper-Kuhn, CM, Schwab, S, Sommer, C, Schneider, A et al. (2007). Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 38: 2165-2172.
14. Dikic, I and Schmidt, MH (2010). Notch: implications of endogenous inhibitors for therapy. Bioessays 32: 481-487.
15. Nichol, D and Stuhlmann, H (2012). EGFL7: a unique angiogenic signaling factor in vascular development and disease. Blood 119: 1345-1352.
16. Lai, K, Kaspar, BK, Gage, FH and Schaffer, DV (2003). Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 6: 21-27.
17. Sims, JR, Lee, SW, Topalkara, K, Qiu, J, Xu, J, Zhou, Z et al. (2009). Sonic hedgehog regulates ischemia/hypoxia-induced neural progenitor proliferation. Stroke 40: 3618-3626.
18. Machold, R, Hayashi, S, Rutlin, M, Muzumdar, MD, Nery, S, Corbin, JG et al. (2003). Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 39: 937-950.
19. Islam, O, Loo, TX and Heese, K (2009). Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res 6: 42-53.
20. Barnabé-Heider, F and Miller, FD (2003). Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J Neurosci 23: 5149-5160.
21. Palma, V and Ruiz i Altaba, A (2004). Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex. Development 131: 337-345.
22. Schmidt, MH, Bicker, F, Nikolic, I, Meister, J, Babuke, T, Picuric, S et al. (2009). Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal. Nat Cell Biol 11: 873-880.
23. Jiang, Y, Wei, N, Lu, T, Zhu, J, Xu, G and Liu, X (2011). Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience 172: 398-405.
24. Ploughman, M, Windle, V, MacLellan, CL, White, N, Doré, JJ and Corbett, D (2009). Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 40: 1490-1495.
25. van Velthoven, CT, Sheldon, RA, Kavelaars, A, Derugin, N, Vexler, ZS, Willemen, HL et al. (2013). Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 44: 1426-1432.
26. Lu, B, Nagappan, G, Guan, X, Nathan, PJ and Wren, P (2013). BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci 14: 401-416.
27. van Velthoven, CT, van de Looij, Y, Kavelaars, A, Zijlstra, J, van Bel, F, Huppi, PS et al. (2012). Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice. Ann Neurol 71: 785-796.
28. Tomac, AC, Agulnick, AD, Haughey, N, Chang, CF, Zhang, Y, Bäckman, C et al. (2002). Effects of cerebral ischemia in mice deficient in Persephin. Proc Natl Acad Sci USA 99: 9521-9526.
29. Bilak, MM, Shifrin, DA, Corse, AM, Bilak, SR and Kuncl, RW (1999). Neuroprotective utility and neurotrophic action of neurturin in postnatal motor neurons: comparison with GDNF and persephin. Mol Cell Neurosci 13: 326-336.
30. Milbrandt, J, de Sauvage, FJ, Fahrner, TJ, Baloh, RH, Leitner, ML, Tansey, MG et al. (1998). Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 20: 245-253.
31. Sirko, S, Behrendt, G, Johansson, PA, Tripathi, P, Costa, M, Bek, S et al. (2013). Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected]. Cell Stem Cell 12: 426-439.
32. Sofroniew, MV (2009). Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638-647.
33. Donega, V, van Velthoven, CT, Nijboer, CH, van Bel, F, Kas, MJ, Kavelaars, A et al. (2013). Intranasal mesenchymal stem cell treatment for neonatal brain damage: longterm cognitive and sensorimotor improvement. PLoS ONE 8: e51253.
34. Ming, GL and Song, H (2011). Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70: 687-702.
35. Mizuguchi, H, Sasaki, T, Kawabata, K, Sakurai, F and Hayakawa, T (2005). Fibermodified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells. Biochem Biophys Res Commun 332: 1101-1106.
36. van der Kooij, MA, Ohl, F, Arndt, SS, Kavelaars, A, van Bel, F and Heijnen, CJ (2010). Mild neonatal hypoxia-ischemia induces long-term motor- and cognitive impairments in mice. Brain Behav Immun 24: 850-856.
37. van Velthoven, CT, Kavelaars, A, van Bel, F and Heijnen, CJ (2010). Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res 68: 419-422.
38. Danielyan, L, Schäfer, R, von Ameln-Mayerhofer, A, Buadze, M, Geisler, J, Klopfer, T et al. (2009). Intranasal delivery of cells to the brain. Eur J Cell Biol 88: 315-324.